Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura G M Daenen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.
Hemasphere|November 3, 2022
High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for ProphylaxisElsemieke Te Linde, Laura J E Boots, Laura G M Daenen, et al.
Hemasphere|June 7, 2021
Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and AdjustMoniek de Witte, Laura G M Daenen, Lotte van der Wagen, et al.
Bone Marrow Transplantation|September 25, 2025
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantationLaura A Michielsen, Moniek A de Witte, Laura G M Daenen, et al.
Annals of Hematology|August 11, 2024
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case seriesCedric Lau, Charlotte van Kesteren, Yong Xin Cao, et al.
Cancer Research|October 7, 2011
Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cellsLaura G M Daenen, Jeanine M L Roodhart, Miranda van Amersfoort, et al.
Bone Marrow Transplantation|April 3, 2023
Graft engineering: how long can you wait, how low can you go, and pandemic readinessKlaartje Nijssen, Kasper Westinga, Anniek Stuut, et al.
The Journal of Urology|June 19, 2012
Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine modelStephanie G C Kroeze, Laura G M Daenen, Maarten W Nijkamp, et al.
Haematologica|September 11, 2025
ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemiaGerben E Breimer, Elisa A Rozeman, Weibel W Braunius, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.
Hemasphere|November 3, 2022
High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for ProphylaxisElsemieke Te Linde, Laura J E Boots, Laura G M Daenen, et al.
Hemasphere|June 7, 2021
Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and AdjustMoniek de Witte, Laura G M Daenen, Lotte van der Wagen, et al.
Bone Marrow Transplantation|September 25, 2025
Pure white cell aplasia following allogeneic hematopoietic stem cell transplantationLaura A Michielsen, Moniek A de Witte, Laura G M Daenen, et al.
Annals of Hematology|August 11, 2024
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case seriesCedric Lau, Charlotte van Kesteren, Yong Xin Cao, et al.
Cancer Research|October 7, 2011
Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cellsLaura G M Daenen, Jeanine M L Roodhart, Miranda van Amersfoort, et al.
Bone Marrow Transplantation|April 3, 2023
Graft engineering: how long can you wait, how low can you go, and pandemic readinessKlaartje Nijssen, Kasper Westinga, Anniek Stuut, et al.
The Journal of Urology|June 19, 2012
Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine modelStephanie G C Kroeze, Laura G M Daenen, Maarten W Nijkamp, et al.
Haematologica|September 11, 2025
ALK-positive histiocytosis and a clonally related chronic myelomonocytic leukemiaGerben E Breimer, Elisa A Rozeman, Weibel W Braunius, et al.
Pageof 3